Drug Type Small molecule drug |
Synonyms Oxiphenbutazone, Oxyphenbutazone (INN), G-29701 + [7] |
Target |
Action inhibitors |
Mechanism COX inhibitors(Cyclooxygenases inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date United States (21 Dec 1960), |
Regulation- |
Molecular FormulaC19H22N2O4 |
InChIKeyCNDQSXOVEQXJOE-UHFFFAOYSA-N |
CAS Registry7081-38-1 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Gout | China | 01 Jan 1995 | |
Gout | China | 01 Jan 1995 | |
Lymphangitis | China | 01 Jan 1995 | |
Lymphangitis | China | 01 Jan 1995 | |
Rheumatoid Arthritis | China | 01 Jan 1995 | |
Rheumatoid Arthritis | China | 01 Jan 1995 | |
Scleritis | United States | 21 Dec 1960 |